Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 2/20 | 0.48 |
| ▸ | PPARD | Q03181 | 2/20 | 0.48 |
| ▸ | PPARA | Q07869 | 2/20 | 0.48 |
| ▸ | CTSD | P07339 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.44 |
| ▸ | CYSLTR2 | Q9NS75 | 7/20 | 0.43 |
| ▸ | CYSLTR1 | Q9Y271 | 7/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10378288 | 0.86 | PPARG (0.58) | PPARGPPARDPPARALMNACYP1A2 | |
| SCHEMBL9728623 | 0.86 | MAPT (0.58) | PPARGPPARDPPARALMNACYP1A2 | |
| SCHEMBL7041532 | 0.84 | CA12 (0.46) | PPARGPPARDPPARACTSDLMNA | |
| SCHEMBL9579627 | 0.83 | CTSD (0.50) | PPARGPPARDPPARACTSDLMNA | |
| SCHEMBL8321013 | 0.83 | CTSD (0.41) | PPARGPPARDPPARACTSDLMNA | |
| SCHEMBL3909320 | 0.83 | CTSD (0.41) | PPARGPPARDPPARACTSDLMNA | |
| SCHEMBL9042867 | 0.82 | PPARG (0.56) | PPARGPPARDPPARALMNACYP1A2 | |
| SCHEMBL9579713 | 0.82 | PPARG (0.50) | PPARGPPARDPPARACTSDLMNA | |
| SCHEMBL6933049 | 0.81 | CTSD (0.58) | PPARGPPARDPPARACTSDLMNA | |
| SCHEMBL10445383 | 0.80 | ALDH1A1 (0.45) | PPARGPPARDPPARALMNACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5155106-A | Reduced side effects | TERUMO KABUSHIKI KAISHA (JP) | 1992-10-13 | — | — | US | disclosed |
| EP-0400144-A1 | CYSTEAMINE DERIVATIVES AND ANTI-RHEUMATIC AGENT CONTAINING SAME | TERUMO KABUSHIKI KAISHA (JP) | 1990-12-05 | — | — | EP | disclosed |